Risk Assessments to avoid Nitrosamines Informa Markets

Risk Assessment: A Unique Strategy to Avoid Nitrosamines

Duration - 76 Minutes

Price - INR-2000 / USD-70
Book Now   Enquire Now  

About the course

This session by leading industry professionals will help you with understanding of Practical Approaches to dothe following risk assessments

  • How to conduct a risk assessment and to identify key factors
  • Applicability to use ICH M7 based cancer risk assessment to the cohort of concern
  • Assessment and communication of risks considering expectations by regulatory authorities

This course was successfully run at the Nitrosamines Impurities Forum 2020 by Informa Markets in India

Speaker Profile

Dr. Venkat Manohar

Indian Institute of Chromatography & Mass Spectrometry (IICMS)

Dr. Aloka Srinivasan

Principal - RAAHA LLC.
Former USFDA

Dr. George Johnson

Swansea University

Dr. Joel Bercu

Senior Director
Gilead Sciences

Website by: Xpoteck